For the Quarter Ending March 2025
North America
The North American Calcium Acetate market displayed fluctuating pricing trends in Q1 2025, shaped by shifting supply conditions, varied demand from key industries, and external economic factors. January began with a price surge, supported by strong demand from the pharmaceutical and food sectors, as well as logistical disruptions that increased delivery times and procurement costs. Port congestion, especially at major hubs like the Port of Los Angeles, coupled with elevated freight rates, strained supply chains and added to the pressure on pricing levels, maintaining market stability despite some challenges.
February saw a shift in market conditions, with prices fluctuating as domestic suppliers faced pressure from excess inventory levels. The softer demand from downstream sectors, coupled with a reduction in freight rates and improved supply availability, resulted in a more balanced market. The relatively stable production costs from key exporting regions allowed suppliers to offer more competitive prices, though ongoing uncertainty around trade policies, particularly with China, contributed to market caution. Buyers adopted a more measured approach, focused on inventory management.
March continued the trend of price fluctuations as the market faced ongoing supply chain challenges and evolving demand patterns. Although freight costs eased further, the imposition of new tariffs and uncertainties around international trade relations added volatility to the market. A slight uptick in industrial demand, particularly from the healthcare sector, provided some price support. However, reduced purchasing activity in other sectors, coupled with fluctuating raw material costs, created a mixed market sentiment, resulting in continued price instability. Overall, Q1 2025 in North America reflected a market in flux, with prices responding to a complex mix of supply pressures, shifting demand, and global trade uncertainties.
Asia Pacific
The Chinese Calcium Acetate export market saw fluctuating pricing trends throughout Q1 2025, primarily influenced by supply-demand dynamics and geopolitical factors. In January, the market experienced downward pressure as weak downstream demand, particularly in the pharmaceutical, healthcare, and food sectors, kept export prices subdued. High inventory levels and limited procurement activity resulted in a softening price environment, with international buyers delaying purchases. This, combined with China's deflationary economic conditions and seasonal fluctuations linked to the Lunar New Year, left the market struggling to recover. Geopolitical uncertainties, including potential tariffs under the incoming U.S. administration, further complicated the outlook, as suppliers engaged in aggressive destocking to clear excess inventory.
February marked a shift in the market as export prices rose due to tightening supply conditions. A reduction in domestic inventory, rising raw material costs, and the 10% tariff increase on Chinese goods bound for the U.S. contributed to heightened volatility. These factors prompted buyers to bulk purchase in anticipation of trade disruptions, while robust demand from the cosmetic and pharmaceutical sectors bolstered market conditions. Manufacturing activity showed signs of recovery, further supporting upward price pressure as China’s PMI indicated a rebound in factory output.
In March, the upward trend continued, driven by tightening supply conditions and strong industrial demand. The combination of lower inventories, robust procurement from key sectors, and rising upstream costs, particularly for Calcium Carbonate, placed pressure on production and supply chains. Although a slight decrease in China’s CPI indicated easing inflation, strong industrial demand, coupled with improved export competitiveness due to reduced freight costs, helped sustain the upward pricing momentum. The U.S. tariffs continued to encourage precautionary purchasing from international buyers, further tightening supply conditions and reinforcing the bullish sentiment in the Calcium Acetate market.
Overall, Q1 2025 saw a shift from a bearish to a more bullish pricing environment as supply-side constraints, strong sectoral demand, and geopolitical risks influenced market dynamics.
Europe
The European Calcium Acetate market, with Germany as a central player, experienced fluctuating price movements throughout Q1 2025, influenced by a combination of supply-side factors, demand shifts, and macroeconomic dynamics. January saw a modest price uptick, driven by early procurement strategies from the pharmaceutical and food sectors, which aimed to secure inventory ahead of expected disruptions due to the Lunar New Year holiday in Asia. Logistical constraints, such as port congestion and extended lead times, coupled with stable demand, helped maintain a generally balanced market despite the added cost pressures from increased freight rates.
In February, the market saw a reversal in pricing trends, with prices softening due to a reduction in downstream demand and improving supply chain conditions. The combination of high inventory levels from pre-holiday stockpiling and declining freight costs contributed to more favorable procurement conditions. Additionally, the stronger euro added to import cost relief, allowing European buyers to manage costs more efficiently. However, cautious purchasing behavior across the pharmaceutical and food industries, driven by broader economic uncertainties, contributed to a more competitive pricing environment.
By March, the market exhibited further price fluctuations, marked by continued soft demand and reduced purchasing activity. Despite ongoing logistical improvements, the weakening euro and trade policy disruptions created a more uncertain market backdrop. Supplier responses to these conditions included offering more competitive prices to move stock, but overall demand remained subdued. Lower raw material costs from key export markets provided some support, but the impact of oversupply and weakened buyer sentiment continued to temper any significant price shifts. Overall, Q1 2025 in Europe showed a progression from early stability to a more cautious market dynamic, marked by price fluctuations in response to fluctuating demand and macroeconomic influences.
For the Quarter Ending December 2024
North America
In Q4 2024, the U.S. calcium acetate market faced several economic challenges, leading to a bearish market sentiment, though a brief recovery was noted mid-quarter. In October, prices declined sharply due to weak trading, rising inventories, and reduced plant operations.
Supplier discounts failed to spur demand as buyers avoided restocking with ample existing stock. The resumption of production worsened the oversupply. Economic factors, including hurricane disruptions, port strikes, and declining crude oil prices, kept the market sentiment subdued. By November, a slight rebound occurred, driven by increased demand from pharmaceuticals, personal care, and other industries aligned with seasonal production.
Elevated freight rates and rising raw material costs pushed import prices higher, while the stabilization of the dollar and increased Asian exports improved trade conditions. However, by December, a downturn followed, with high inventories, weak demand from key sectors, and aggressive pricing from Chinese imports. U.S. suppliers engaged in heavy destocking, highlighting the need for better supply chain management and strategic inventory planning.
Asia Pacific
During the entire fourth quarter of 2024, the Chinese calcium acetate market displayed a bearish trend due to supply-demand imbalances and price volatility. October witnessed a sharp price drop driven by aggressive destocking by suppliers, weaken purchasing, and oversupply conditions. The shift from scarcity to surplus, coupled with weak regional and global demand, dampened trading activity and heightened price sensitivity in downstream sectors. November saw a slight price recovery, spurred by increased post-holiday demand from Western markets and improved freight conditions. Rising feed acetic acid prices also contributed to higher production costs, stabilizing prices and improving supplier margins. This created a favourable seller's market, enhancing Chinese suppliers' global position and boosting trade volumes, and benefitting them in terms of higher profit margins. However, December marked a downturn, as indicated by a dip in the Manufacturing PMI, reflecting ongoing economic challenges. Weak foreign orders, stagnant domestic demand, and the potential for new tariffs under President-elect Trump led to further destocking and discounting, exacerbating the supply-demand imbalance.
Europe
Similar to that of other importing nations, the German Calcium acetate market exhibited fluctuating price trends, concluding on a negative note with a modest rise witnessed in the middle of quarter. In October, prices fell due to weak downstream demand, cautious procurement, and low inventories. The euro's depreciation against the U.S. dollar further exacerbated import costs, reinforcing the bearish market sentiment. Sectors like food & beverage and preservatives reduced purchases amidst economic uncertainty, while competition from cheaper imports, especially from China, pressured prices. November saw a rebound in prices, driven by solid domestic consumption in industries such as food, beverages, pharmaceuticals, and cosmetics. Sufficient supply from major exporters, coupled with high seasonal shipping costs, led to elevated import prices, benefiting traders with improved margins. However, December experienced another downturn, marked by a steady decline in regional prices and need-based transactions. Minimal impact from seasonal logistics disruptions at ports like Rotterdam and Hamburg was observed, while high supplier inventories led to aggressive pricing, highlighting the need for flexible inventory management and adaptable supply chain strategies.
For the Quarter Ending September 2024
North America
In the third quarter of 2024, the Calcium Acetate market in North America experienced a period of moderate growth amidst mixed market conditions. While supply-side pressures were manageable, the market grappled with tepid downstream demand and cautious purchasing trends, leading to stable but limited transaction volumes overall.
Price recovery was notable after a prolonged downturn, with sporadic upticks driven by increased downstream orders and improved shipment dynamics. End-user negotiations saw slight upward adjustments, reflecting consistent consumption across sectors where feedstock acquisition remained favorable.The rising cost of Acetic acid , a key raw material, added pressure to pricing structures, pushing Calcium Acetate prices upward.
Nevertheless, mid-quarters witnessed a dip in import prices, partly due to weakened demand in critical sectors like pharmaceuticals and preservatives. This decline, alongside oversupply concerns, economic slowdown, increased availability of cheaper alternatives, and currency fluctuations, exerted downward pressure on market prices, influencing purchasing patterns among cautious buyers. Shorter supplier lead times and restrained inventory purchases further highlighted market hesitancy. As the quarter drew to a close, a slight recovery in end-user demand balanced out excess inventories, providing some stability to the market.
APAC
In Q3 2024, the APAC region witnessed a notable uptrend in Calcium Acetate pricing. Market dynamics were influenced by various key factors, such as strong demand from multiple sectors, limited supply, and favourable cost-support from raw materials. These factors collectively contributed to the price surge observed throughout the quarter. In China specifically, which experienced the most significant price fluctuations, the pricing environment reflected a positive trajectory. The quarter showcased a correlation between increasing temperatures, heightened demand for Calcium Acetate, and a surge in production costs ahead of varied feedstock acetic acid prices. However, the market witnessed a steady drop in the month of august 2024 with supply side balanced by the overall demand dynamics. With respect to the supply aspect concerning the market sentiments, following a continuous upward price trend, Inventories concerning the Calcium Acetate. were high, with limited inquiries arriving from the end-users. This surplus strained supplier, particularly regarding storage costs, compelling merchants to reduce prices to offload excess stock. While some market support came from maintenance activities and modest downstream purchases, Despite a slight decline in the middle of the quarter, the overall trend remained upward. The quarter-ending price of USD 930/MT for Calcium Acetate IR Grade FOB Shanghai in China, signifying a stable and positive pricing environment.
Europe
In Q3 2024, the European Calcium Acetate market exhibited a largely stable price trajectory, akin to patterns observed across North America. Germany led the region in price adjustments, reflecting intensified market engagement, with increased trading volumes, high inquiry rates, and strong participant engagement. Price growth was driven by a rise in bulk purchases, steady costs for key raw materials maintaining production expenses, and increased inquiries from downstream poultry sectors. Export volumes from major producers rose, with traders focusing on profitability amid tightening logistical channels and elevated freight costs, particularly affecting Calcium Acetate imports from China. Mid-quarter, however, the market encountered a steady price downturn, influenced by reduced production costs as energy prices dropped and acetic acid became less expensive. Additionally, weaker demand across multiple sectors, notably in food preservatives and pharmaceuticals, put downward pressure on the market. Despite these factors, the quarter closed with a modest 1% increase in Calcium Acetate prices from the previous quarter, reflecting the mixed dynamics of rising logistics costs against a backdrop of softening production and demand pressures. This resulted in an overall steady but cautious market outlook across Europe.
For the Quarter Ending June 2024
North America
In Q2 2024, the North American Calcium Acetate market followed the market trend witnessed in key producing nations. The quarter initiated witnessing an optimistic trend with prices rising at a steady level. Trades within the US market focused on bulk purchasing ahead of increased demand from end-users. This was further attributed to a slight ease in freight charges and continuous appreciation of the dollar against the producing nation’s currencies. However, the market witnessed an upside-down trajectory as May commenced. This downward trajectory of prices was initially triggered by a gradual reduction in overseas market trade momentum, as traders grappled with higher inventories accumulated over the past months. This trend was further amplified by the ramped-up production capacity of manufacturers across the Apac region, particularly China, along with the entry of new players into the market. The resulting surplus supply exerted downward pressure on export prices, intensifying competition among traders. In response to the evolving market conditions, manufacturers were compelled to lower their prices in a bid to attract customers and maintain their global market position. This strategic move was further influenced by a discernible shift in consumer purchasing sentiments towards alternative excipients, such as calcium propionate and sorbic acid. The altered preferences created a supply-demand imbalance among traders in the regional market, dampening overall market transactions during May. This trend continued until the final weeks of June, with traders being highly concerned about the higher stockpiles at the warehouses. The terminal market consumption remains at a lower level, with downstream purchasing enthusiasm notably weak. This lack of robust demand is a critical concern, as it suggests that the broader economic improvements have not translated into increased consumption of Calcium Acetate. Overall, the correlation between supply and demand further showcased a consistent surplus, compelled traders to adopt aggressive pricing strategies throughout the month to prevent further product deterioration and higher cost of storage, resulting in a continuous price drop even in June.
Asia Pacific
The APAC region particularly China experienced a significant decline in Calcium Acetate prices during the second quarter of 2024 with a steady rise witnessed at the beginning of the quarter. In April, the market dynamics of Calcium Acetate demonstrated a sustained upward trajectory in trade originating from China, driven by a continuous increase in demand from downstream and overseas sectors including food, pharmaceuticals, water treatment, and others. On the demand side, inquiries from the overseas market continued to show optimism, supported by higher imports owing to a persistent depreciation of the Chinese Yuan against the US dollar, which bolstered the market's overall resilience and resulted in more competitively priced material availability globally. Moreover, the reduction in freight costs from China has further bolstered the overall rise in market transactions among buyers and suppliers in trading nations, facilitating increased export momentum of Calcium Acetate in April, supporting the overall positive trend. However, the trend was reversed as the quarter moved forward in May 2024. This downturn was primarily driven by weakening international trade and high inventory levels. Various market experts stated that ahead of previously increased production capacity by manufacturers owing to anticipated higher inquiries, resulted in an oversupply situation, which was further intensified by new market entrants. This resulted in an affected market trading atmosphere as inquiries did not meet the market expectations concerning the supply side. As a result, in order to maintain market share and attract customers amid rising competition and changing consumer preferences, manufacturers strategically focused on reducing their exporting prices. Moreover, as of May 2024, With respect to the market activity in general, the National Bureau of Statistics’ Manufacturing Purchasing Managers’ Index (PMI) fell from 50.4 in April to 49.5 in May, undershooting market expectations. Consequently, the index moved below the 50.0 no-change threshold, signaling a worsening in manufacturing sector operating conditions from the previous month. The headline prints chiefly reflected worse readings for new orders and output. The enthusiasm for procurement remained weakened, and the price of new orders was close to cost. Further, manufacturers considerably weakened their profit sentiment to destroy their inventories. This uncertainty could have led to a cautious approach in purchasing decisions, as buyers were hesitant to place large orders or commit to long-term contracts with Chinese suppliers, creating significant imbalances in supply-demand dynamics and traders grappling with higher inventories. This trend continued to follow until the final weeks of June, marking the bearish trend in terms of international market transactions, with an increased prevalence of a "buy up" rather than "buy down" mentality among purchasers.
Europe
During the entire Q2 2024, the European Calcium Acetate market experienced an overall downturn due to multiple converging factors that exerted downward pressure on prices, specifically, Germany witnessed the most pronounced price fluctuations within the region. The overarching theme for this quarter was the interplay of reduced downstream purchasing in key end-users and elevated freight charges ahead of the geopolitical stabilization affecting supply chains. Following the market trend of key producing nations which grappled with heightened inflationary pressures, constrained purchasing power, and suppressed demand across various end-user sectors, particularly the food industry, the importing prices of calcium acetate dropped throughout the quarter with merchants highly resistant to newer procurements. The market's bearish stance was exacerbated by substantial pre-existing inventories which were held in the initiation of the quarter I.e., April 2024. The market witnessed a significant rise in end-user procurements. Anticipation of further rise in demand and the notable plant shutdowns in key producing nations resulting in an interruption at major production facilities, further disrupted the supply chain, leading to higher procurements and reduced market activity. However, as may commence, the market demand did not materialize as per the expectations, thereby supporting a significant drop. This was further supported by a depreciation of the euro against the dollar which kept the imported cost of the goods on the northerly side, thereby creating reluctance among the traders for newer procurements. This trend continued until the end of June, with traders gradually focused on clearing their inventories instead of newer procurements. Overall, the pricing environment for Calcium Acetate in Q2 2024 in Europe exhibited positivity, with pronounced prices reflecting fluctuations stemming from limited demand, higher supplies, and trade disputes leading to higher costs of transportation.
